SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-089165
Filing Date
2019-03-28
Accepted
2019-03-28 06:05:33
Documents
4
Period of Report
2019-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d691844d8k.htm 8-K 29845
2 EX-10.1 d691844dex101.htm EX-10.1 59540
3 EX-99.1 d691844dex991.htm EX-99.1 12563
4 GRAPHIC g691844img001.jpg GRAPHIC 14091
  Complete submission text file 0001193125-19-089165.txt   122771
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 19709844
SIC: 2834 Pharmaceutical Preparations